From: Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis
Group
N
Treatment
Dose
Group 1
10
control mAb
1 mg/week
Group 2
Anti-IL-6
Group 3
5 mg/week